Design Synthesis and Characterization of Responsive MR Contrast Agents Sensit...
Design Synthesis and Characterization of Responsive MR Contrast Agents Sensitive to Glutamate
Functional Magnetic Resonance Imaging (fMRI) based on Blood-Oxygen-Level-Dependent (BOLD) contrast is currently the mainstay of neuroimaging, whose ever growing applications provide a wealth of information regarding the human brai...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SAF2017-91824-EXP
IMAGEN DE RESONANCIA MAGNETICA DE TRACTOS NEURALES ACTIVOS
18K€
Cerrado
BREAKBEN
Breaking the Nonuniqueness Barrier in Electromagnetic Neuroi...
4M€
Cerrado
EQC2019-006401-P
Equipamiento científico para la implementación de una unidad...
114K€
Cerrado
Neuronal MRI
Neuronal MRI Harnessing chemical exchange between N Acetyla...
149K€
Cerrado
SAF2008-00678
MEDIDA DE PERFUSION CEREBRAL EN PATOLOGIA USANDO LA TECNICA...
85K€
Cerrado
C-MORPH
Noninvasive cell specific morphometry in neuroinflammation a...
1M€
Cerrado
Información proyecto GLURESPROBES
Líder del proyecto
UNIVERSITY OF DURHAM
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
181K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Functional Magnetic Resonance Imaging (fMRI) based on Blood-Oxygen-Level-Dependent (BOLD) contrast is currently the mainstay of neuroimaging, whose ever growing applications provide a wealth of information regarding the human brain. The chief advantage of BOLD-fMRI is its non-invasive nature and excellent coverage, but it is limited by poor temporal and spatial resolution, and its surrogate nature. In fact, BOLD imaging, as well as other fMRI methods, are insufficient for a detailed study of the neural networks that underly human or animal cognition. We propose to develop a new approach. The aim is to study exogenous MR contrast agents that are ‘responsive’ biochemical functional markers, capable of detecting neuronal activity in real time and translating it into changes of MR contrast. Our objective is to develop glutamate responsive contrast agents to image changes in different parts of the brain upon neural activation. We also aim to improve the sensitivity of these bio-responsive agents by introducing additional modality for Positron Emission Tomography (PET) in the molecules. Initially, novel selective classes of specific, efficacious and optimized Glutamate receptors antagonists along with contrast enhancing macrocyclic lanthanide-chelates, will be developed. The initiatives in chemistry include both tailored organic synthesis and complexation of non-toxic metallo-pharmaceuticals, whose ligand design is dictated by the desired structure-activity relationship. Glutamate receptor sensitive specific extracellular responsive contrast agents will be considered. Every agent will be characterized by different chemical methods and finally evaluated by means of in vitro MR/PET measurements in simulated physiological conditions.